EZH2 and breast cancer: Other alterations in the epigenome have been described in MCF-7 cells in mice exposed in utero to DES, such as the increase of the Enhancer of Zeste Homolog 2 (EZH2), a histone methyltransferase that has been linked to breast cancer risk, and the increase in Histone H3 trimethylation [68].